Stoke Therapeutics expands board to 10 directors, appoints G. Clare Kahn as R&D chair
Filed April 7, 2026 · Period ending April 3, 2026 · ~1 min read
3 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade STOK commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 5, 2026 5:16 PM